Brief: Bubs Australia Submits Clinical Trial Data To US FDA
16/06/2025 02:26
June 16 (Reuters) - Bubs Australia Ltd BUB.AX: BUBS SUBMITS CLINICAL TRIAL DATA TO US FDA CONFIRM FORMALLY LODGED ITS NEW INFANT FORMULA SUBMISSION WITH US FDA TO COVER ALL THREE BUBS INFANT MILK FORMULAS Further company coverage: BUB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump